Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Apr;32(4):305-14.
doi: 10.1086/658938.

Collaborative cohort study of an intervention to reduce ventilator-associated pneumonia in the intensive care unit

Affiliations

Collaborative cohort study of an intervention to reduce ventilator-associated pneumonia in the intensive care unit

Sean M Berenholtz et al. Infect Control Hosp Epidemiol. 2011 Apr.

Abstract

Objective: To evaluate the impact of a multifaceted intervention on compliance with evidence-based therapies and ventilator-associated pneumonia (VAP) rates.

Design: Collaborative cohort before-after study.

Setting: Intensive care units (ICUs) predominantly in Michigan.

Interventions: We implemented a multifaceted intervention to improve compliance with 5 evidence-based recommendations for mechanically ventilated patients and to prevent VAP. A standardized CDC definition of VAP was used and maintained at each site, and data on the number of VAPs and ventilator-days were obtained from the hospital's infection preventionists. Baseline data were reported and postimplementation data were reported for 30 months. VAP rates (in cases per 1,000 ventilator-days) were calculated as the proportion of ventilator-days per quarter in which patients received all 5 therapies in the ventilator care bundle. Two interventions to improve safety culture and communication were implemented first.

Results: One hundred twelve ICUs reporting 3,228 ICU-months and 550,800 ventilator-days were included. The overall median VAP rate decreased from 5.5 cases (mean, 6.9 cases) per 1,000 ventilator-days at baseline to 0 cases (mean, 3.4 cases) at 16-18 months after implementation (P < .001) and 0 cases (mean, 2.4 cases) at 28-30 months after implementation (P < .001). Compared to baseline, VAP rates decreased during all observation periods, with incidence rate ratios of 0.51 (95% confidence interval, 0.41-0.64) at 16-18 months after implementation and 0.29 (95% confidence interval, 0.24-0.34) at 28-30 months after implementation. Compliance with evidence-based therapies increased from 32% at baseline to 75% at 16-18 months after implementation (P < .001) and 84% at 28-30 months after implementation (P < .001).

Conclusions: A multifaceted intervention was associated with an increased use of evidence-based therapies and a substantial (up to 71%) and sustained (up to 2.5 years) decrease in VAP rates.

PubMed Disclaimer

Similar articles

Cited by

  • Implementing strategies to prevent infections in acute-care settings.
    Trivedi KK, Schaffzin JK, Deloney VM, Aureden K, Carrico R, Garcia-Houchins S, Garrett JH Jr, Glowicz J, Lee GM, Maragakis LL, Moody J, Pettis AM, Saint S, Schweizer ML, Yokoe DS, Berenholtz S. Trivedi KK, et al. Infect Control Hosp Epidemiol. 2023 Aug;44(8):1232-1246. doi: 10.1017/ice.2023.103. Epub 2023 Jul 11. Infect Control Hosp Epidemiol. 2023. PMID: 37431239 Free PMC article.
  • A National Implementation Project to Prevent Healthcare-Associated Infections in Intensive Care Units: A Collaborative Initiative Using the Breakthrough Series Model.
    Tuma P, Vieira Junior JM, Ribas E, Silva KCCD, Gushken AKF, Torelly EMS, de Moura RM, Tavares BM, Prandini CM, Borem P, Delgado P, Ue LY, de Barros CG, Vernal S; Collaborative Study Group “Saúde em Nossas Mãos”. Tuma P, et al. Open Forum Infect Dis. 2023 Mar 9;10(4):ofad129. doi: 10.1093/ofid/ofad129. eCollection 2023 Apr. Open Forum Infect Dis. 2023. PMID: 37077504 Free PMC article.
  • Strategies to prevent Clostridioides difficile infections in acute-care hospitals: 2022 Update.
    Kociolek LK, Gerding DN, Carrico R, Carling P, Donskey CJ, Dumyati G, Kuhar DT, Loo VG, Maragakis LL, Pogorzelska-Maziarz M, Sandora TJ, Weber DJ, Yokoe D, Dubberke ER. Kociolek LK, et al. Infect Control Hosp Epidemiol. 2023 Apr;44(4):527-549. doi: 10.1017/ice.2023.18. Infect Control Hosp Epidemiol. 2023. PMID: 37042243 Free PMC article. No abstract available.
  • The Impact of Care Bundles on Ventilator-Associated Pneumonia (VAP) Prevention in Adult ICUs: A Systematic Review.
    Mastrogianni M, Katsoulas T, Galanis P, Korompeli A, Myrianthefs P. Mastrogianni M, et al. Antibiotics (Basel). 2023 Jan 20;12(2):227. doi: 10.3390/antibiotics12020227. Antibiotics (Basel). 2023. PMID: 36830138 Free PMC article. Review.
  • Impact of a national collaborative project to improve the care of mechanically ventilated patients.
    Arabi YM, Al Aseri Z, Alsaawi A, Al Khathaami AM, Al Qasim E, Alzahrani AA, Al Qarni M, Abdukahil SAI, Al-Dorzi HM, Alattasi A, Mandourah Y, Alaama TY, Alabdulaali MK, Alqahtani A, Shuaibi A, Al Qarni A, Alkatheri M, Al Hazme RH, Vishwakarma RK, Aldibasi O, Alshahrani MS, Attia A, Alharthy A, Mady A, Abdelrahman BA, Mhawish HA, Abdallah HA, Al-Hameed F, Alghamdi K, Alghamdi A, Almekhlafi GA, Qasim SAH, Al Haji HA, Al Mutairi M, Tashkandi N, Alabbasi SO, Al Shehri T, Moftah E, Kalantan B, Matroud A, Naidu B, Al Zayer S, Burrows V, Said Z, Soomro NA, Yousef MH, Fattouh AA, Tahoon MA, Muhammad M, Alruwili AM, Al Hanafi HA, Dandekar PB, Ibrahim K, AlHomsi M, Al Harbi AR, Saleem A, Masih E, Al Rashidi NM, Amanatullah AK, Al Mubarak J, Al Radwan AAA, Al Hassan A, Al Muoalad S, Alzahrani AA, Chalabi J, Qureshi A, Al Ansari M, Sallam H, Elhazmi A, Alkhaldi F, Malibary A, Ababtain A, Latif A, Berenholtz SM; Saudi Critical Care Trials Group. Arabi YM, et al. PLoS One. 2023 Jan 30;18(1):e0280744. doi: 10.1371/journal.pone.0280744. eCollection 2023. PLoS One. 2023. PMID: 36716310 Free PMC article. Clinical Trial.

Publication types

MeSH terms

LinkOut - more resources